Our mission is to provide a forum for biospace professionals
engaged in all segments of the industry to network, expand
technical knowledge and connect our members with companies
who can benefit from their expertise.
WELCOME
Welcome and thank you for
visiting The Bio2Device Group's official website.
The Bio2Device Group is the first volunteer organization of its kind in Silicon Valley to focus on the convergent needs of engineers, scientists, business, regulatory and other biospace professionals working in the biotechnology, medical device, diagnostics and pharmaceutical industries.
The Bio2Device Group's goal is to create interdisciplinary opportunities for this unique community of talented professionals, to exchange information, educate, and network with other Bay Area Biospace Professionals. The Bio2Device Group meets on Tuesday starting at 8:30 AM at 505 West Olive, Sunnyvale, Room 510 . On the second Tuesday of each month, we hold an evening meeting instead of the daytime meeting. That meeting (RSVP required) begins with a light meal at 6 p.m. and is held at
TIPS Group at 1000 Elwell Court , Palo Alto , CA 94303
.
This week's meeting is described below. A calendar of B2DG and Bay Area Biospace events can be found at This Week's BioSpace Events .
Electroactive
Polymer Devices for Biomedical Systems
John Bashkin, Ph.D., MBA
Business Development
Director
Artificial Muscle, Inc
Dr.
Bashkin will speak about Artificial Muscle, Inc.
(AMI) and the company’s activities in the design and manufacture of smartMOVETM actuators and sensors based on its
proprietary electroactive polymer technology and their
usage in biomedical systems.He will
differentiate SmartMOVE devices from other
competitive products and explain their benefit alternatives to traditional
electromagnetic or piezoelectric actuators, small motors, or sensors. He will also cover how these attributes
provide a benefit at the component and system level designs, allowing for a
reduction in parts count, power supply size and cooling requirements.
Dr. John Bashkin joined Artificial
Muscle, Inc. as Director of Business Development in 2007. Prior to that he spent seven years as Director
of Business Development at SRI International, specializing in medical device
and life science technologies, out-licensing, and contract negotiation. From 1992-2000, Dr. Bashkin
was a senior scientist and technology research manager for Molecular Dynamics
and Amersham Biosciences, where he led the
development of the first high throughput DNA sequencing system that was used
for much of the Human Genome Project. He
received his B.S. in chemistry and physics from the University
of Arizona in 1983, his Ph.D. in
chemistry from IndianaUniversity in 1988 and his MBA from Santa ClaraUniversity
in 2000.